• Explore /
  • Poster
  • / The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic <em>BRCA</em> or <em>PALB2</em> variants who were treated with maintenance rucaparib.

The identification of reversion mutations in patients with advanced pancreatic cancer and germline or somatic BRCA or PALB2 variants who were treated with maintenance rucaparib.

Abstract Poster

Authors

Timothy Brown

Timothy J Brown

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;

Timothy J Brown , Arielle Yablonovitch , Jennifer Yen , Lesli A. Kiedrowski , Erica L. Carpenter , Katherine Nathanson , Susan M. Domchek , Kim Anna Reiss

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 734)

DOI

10.1200/JCO.2023.41.4_suppl.734

Abstract #

734

Poster Bd #

M1

Abstract Disclosures

Similar Posters

First Author: Timothy J Brown

First Author: Kim Anna Reiss

First Author: Leslie A. Bucheit

First Author: Kim Anna Reiss